Insider Trading February 23, 2026 10:55 AM

Itron HR Executive Sells $373,767 in Stock as Company Posts Strong Q4 Results

Laurie Ann Pulatie-Hahn disposes of 3,755 shares to cover tax withholdings; Itron reports earnings and outlines convertible note offering

By Derek Hwang ITRI

Laurie Ann Pulatie-Hahn, Itron's senior vice president of human resources, sold 3,755 shares on February 19, 2026, for $99.5385 per share, generating $373,767. The transaction was disclosed on a Form 4 filed with the Securities and Exchange Commission. Itron recently reported better-than-expected fourth-quarter 2025 results and announced a private offering of convertible senior notes due 2032, moves that market analysts have reacted to with upgrades and a higher price target from some firms.

Itron HR Executive Sells $373,767 in Stock as Company Posts Strong Q4 Results
ITRI

Key Points

  • Itron SVP of HR Laurie Ann Pulatie-Hahn sold 3,755 shares on February 19, 2026, at $99.5385 per share for $373,767; sale was disclosed on a Form 4 with the SEC.
  • The stock traded at $98.02 and had gained 11.4% over the past week; Pulatie-Hahn now directly owns 33,679 shares following the transaction.
  • Itron beat Q4 2025 expectations with EPS of $2.46 (vs. $2.19 expected) and revenue of $572 million (vs. $561.48 million expected); the company also announced a $600 million convertible note offering due 2032 with a $90 million option.

Laurie Ann Pulatie-Hahn, who serves as senior vice president of human resources at Itron, Inc. (NASDAQ: ITRI), executed a sale of 3,755 common shares on February 19, 2026. The shares were sold at $99.5385 apiece, producing a total transaction value of $373,767, according to a Form 4 filing with the Securities and Exchange Commission.

Following the disposition, Pulatie-Hahn directly holds 33,679 shares of Itron common stock. The filing indicates the shares were sold to satisfy tax withholding obligations tied to the vesting of a performance-based restricted stock unit award.

At the time of the report, Itron shares were trading at $98.02, reflecting an 11.4% increase over the previous week.

Separately, Itron released fourth-quarter results for 2025 that outperformed analyst expectations. The company reported earnings per share of $2.46, above the forecasted $2.19, and recorded revenue of $572 million versus analysts' estimates of $561.48 million.

Market reactions to the quarterly report included analyst coverage moves. Oppenheimer raised its price target for Itron to $133 while maintaining an Outperform rating. Baird upgraded the stock to Outperform from Neutral, citing opportunities in utility grid modernization as a factor behind its decision.

In addition to the earnings release and analyst updates, Itron announced plans for a private offering of $600 million in convertible senior notes due 2032, with an option for initial purchasers to acquire an additional $90 million in notes. The company said final terms of the offering - including the interest rate and the initial conversion rate - will be determined at pricing.

Taken together, the insider sale tied to tax withholding, the stronger-than-expected quarterly results, analyst adjustments and the planned convertible note offering are presented by the company as developments that reflect positively on Itron's financial health and strategic positioning in the market.

Risks

  • Final terms of the private convertible senior note offering - including interest rate and initial conversion rate - remain undetermined, which could affect company financing costs and shareholder dilution - impacts capital markets and investor sentiment.
  • Insider share sales, even when executed to cover tax withholding from vested awards, can be perceived variably by market participants and may influence short-term stock perception - impacts equity market reaction.
  • Analyst ratings and price targets can change; while some firms upgraded Itron following results, future revisions could alter investor expectations - impacts institutional investor positioning in utilities and grid modernization sectors.

More from Insider Trading

Edwards Lifesciences CEO Executes Multi-Million Dollar Share Sale via Pre-Set Trading Plan May 12, 2026 Covista CFO Executes $1.26 Million Stock Sale via Pre-Scheduled Trading Plan May 12, 2026 Covista Executive Executes Planned Share Sale Amidst Corporate Growth and Financial Restructuring May 12, 2026 Covista Executive Executes $1.22 Million Stock Sale Under Pre-Planned Trading Program May 12, 2026 Ameriprise Financial Director Executes Stock Sale Amid Strong Earnings Performance May 12, 2026